Rossari Biotech Ltd

NSE: ROSSARI · BSE: 543213 · Chemicals & Petrochemicals · 37 announcements

Share price: ₹422.90
Market cap: ₹2,343 Cr
Revenue (annual): ₹2,396 Cr
Net profit (annual): ₹149.2 Cr
P/E (TTM): 15.5×Sector 36.8×
Promoter holding: 68.14%-0.01% QoQ
FII holding: 2.03%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

18 Jul 2026 17:37 IST NSE

Rossari Biotech Merger & Restructuring Worth ₹24 Cr

Rossari Biotech is selling its wholly-owned subsidiary, Rossari International Limited Company, to its Singapore subsidiary for approximately ₹24 Crore. This internal restructuring completes by March 2027.

Value: ₹24.00 Cr

Read the filing ↗

3 Apr 2026 20:38 IST BSE

Merger & Restructuring

Rossari Biotech Merger & Restructuring Worth ₹10 Cr

Rossari Biotech's subsidiary, Unitop Chemicals, approved the sale of its Mumbai office premises for approximately ₹10 Crore. The transaction is expected to conclude by Q2 FY27. As no business operations are conducted there, the sale will not impact the company's core operations.

Value: ₹10.00 Cr
Execution: by end of Q2 FY27

Read the filing ↗